Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?
Pembrolizumab and chemotherapy (chemoimmunotherapy) were administered to 2 head and neck squamous cell carcinoma (HNSCC) patients with extremely advanced local tumors and distant metastases with palliative intent. However, they demonstrated strikingly good responses and achieved remission. Expanded...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457411/ https://www.ncbi.nlm.nih.gov/pubmed/34584700 http://dx.doi.org/10.1002/ccr3.4793 |